Another meta-analysis found that SGLT2 inhibitors had similar risks of hypoglycaemia, urinary tract infection, genital infection, hypovolemia, and fracture compared to placebo in Japanese patients (57). Here, SLC5A2 is linked to Hypoglycemia.